Castle Biosciences
CSTL
CSTL
159 hedge funds and large institutions have $916M invested in Castle Biosciences in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $1.41B → $916M (-$498M)
56% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 48
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
159
Holding in Top 10
–
Calls
$313K
Puts
$222K
Top Buyers
| 1 | +$26.7M | |
| 2 | +$16.3M | |
| 3 | +$15.1M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$12.3M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$8.14M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$23.8M | |
| 3 | -$19.8M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$12.4M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$9.84M |